TL;DR: Nemorubicin (CAS 108943-08-4) is a chemical compound with molecular formula C32H37NO13 and molecular weight 643.2265 g/mol, supplied by CoreyChem (Career Henan Chemical Co., Ltd.) with ISO-certified quality and global shipping.
(7S,9S)-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-7-[5-hydroxy-4-[(2S)-2-methoxymorpholin-4-yl]-6-methyloxan-2-yl]oxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione
Also Known As: Nemorubicin, (7S,9S)-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-7-[5-hydroxy-4-[(2S)-2-methoxymorpholin-4-yl]-6-methyloxan-2-yl]oxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione
| Molecular Formula | C32H37NO13 |
| Molecular Weight | 643.2265 g/mol |
| XLogP | 1.7 |
| Topological Polar Surface Area (TPSA) | 202.0 Ų |
| Hydrogen Bond Donors | 5 |
| Hydrogen Bond Acceptors | 14 |
| Rotatable Bonds | 7 |
| Exact Mass | 643.2265 Da |
| Heavy Atoms | 46 |
| Complexity | 1160.0 |
| SMILES | CC1C(C(CC(O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N6CCO[C@@H](C6)OC)O |
| InChIKey | CTMCWCONSULRHO-VOAJIXTCSA-N |
The XLogP value of 1.7 suggests moderate lipophilicity, balancing water solubility and membrane permeability for Nemorubicin. The TPSA of 202.0 Ų indicates high polarity, suggesting Nemorubicin may have limited membrane permeability but good aqueous solubility. Following Lipinski's Rule of Five, Nemorubicin has 5 hydrogen bond donor(s) and 14 hydrogen bond acceptor(s), which may warrant consideration for formulation optimization.
The CAS number of Nemorubicin is 108943-08-4.
The molecular formula of Nemorubicin is C32H37NO13.
The molecular weight of Nemorubicin is 643.2265 g/mol.
You can request a quote for Nemorubicin directly from CoreyChem. Contact us or email [email protected] for pricing and availability.
Yes, CoreyChem provides custom synthesis services for Nemorubicin and related compounds. Contact us with your specific requirements including quantity, purity, and timeline.
Request a quote for CAS 108943-08-4. Our professional technical team will respond with pricing and lead time.